Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Three engineers have been killed in an explosion at a manufacturing facility in India.
Roche is celebrating the decision taken by the FDA to approve Polivy in combination with bendamustine and Rituxan (BR) as a treatment for relapsed...
Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges brought...
Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO James Ward-Lilley is to step down from his role...
French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with Paul Hudson, CEO at...
Biogen's diroximel fumarate impresses at Phase 3 in relapsing multiple sclerosis; Pfizer supressed research suggesting arthritis drug Enbrel reduced...
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand their patients...
Janssen has lifted the curtain on Phase 3 study findings for Darzalex  plus bortezomib, thalidomide and dexamethasone (VTd) before and after...
Phase 3 data from ASCO 2019 has shown Janssen’s leukaemia drug Imbruvica (ibrutinib) had significant benefits over ofatumumab.
Amgen has unveiled the first clinical data for its investigational KRAS inhibitor AMG 510, the first such therapy to reach clinical stage,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches